The first CTX-M-15 -lactamase was found in several en-terobacterial isolates from India in 1999 (4). Worldwide spread of CTX-M-15 -lactamases is now well documented (1–5, 7, 8, 12). CTX-M -lactamases confer high-level resistance to cefo-taxime, ceftriaxone, and aztreonam and are well inhibited by clavulanate and tazobactam (10, 11). Klebsiella pneumoniae 193KFFUL was isolated from a blood culture in September 2003 at the Hospital de Santa Maria. The clinical isolate was resistant to cefotaxime and cefepime (MIC, 256 g/ml) and ceftazidime and aztreonam (MIC, 96 g/ml) and susceptible to imipenem (MIC, 0.125 g/ml). Tazobactam and clavulanate restored the activities of piperacillin, cefo-taxime, ceftazidime, and cefepime as determined by E-test...
Objective: The aim of this study was to characterize the CTX-M genes in clinical isolates of Klebsie...
Escherichia coli and Klebsiella pneumoniae cause a wide range of infections. Multidrug-resistance st...
Extended-spectrum β-lactamases (ESBL) producing bacteria have been increasingly reported in both hos...
Rapid spread of CTX-M type extended-spectrum beta-lactamases (ESBL) between the members of Enterobac...
Rapid spread of CTX-M type extended-spectrum beta-lactamases (ESBL) between the members of Enterobac...
A cefotaxime-resistant Klebsiella pneumoniae ML4313 was obtained from a patient from intensive care ...
Background: Production of β–lactamases by enterobacteriacea, especially Klebsiella pneumoniae, is on...
A total of 23 clinical isolates (15 Escherichia coli and 8 Klebsiella pneumoniae ), resistant to ...
Purpose: Plasmid-encoded CTX-M-group of extended-spectrum β-lactamases (ESBLs) represent a significa...
The CTX-M-15 extended-spectrum β-lactamase (ESBL) was recently identified in Enterobac-teriaceae iso...
Objective: Extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections cause difficu...
Background & Objectives: CTX-M-type β-lactamases are increasingly becoming the predominant ESBLs glo...
Background: Extended-spectrum β-lactamases (ESBLs) is one of the most important mechanisms of resis...
Introduction: The wideuse of beta-lactam antibacterial agents in the treatment of bacterial infectio...
Background: The aim of this study was to determine a nation-wide prevalence of Ambler class A and D ...
Objective: The aim of this study was to characterize the CTX-M genes in clinical isolates of Klebsie...
Escherichia coli and Klebsiella pneumoniae cause a wide range of infections. Multidrug-resistance st...
Extended-spectrum β-lactamases (ESBL) producing bacteria have been increasingly reported in both hos...
Rapid spread of CTX-M type extended-spectrum beta-lactamases (ESBL) between the members of Enterobac...
Rapid spread of CTX-M type extended-spectrum beta-lactamases (ESBL) between the members of Enterobac...
A cefotaxime-resistant Klebsiella pneumoniae ML4313 was obtained from a patient from intensive care ...
Background: Production of β–lactamases by enterobacteriacea, especially Klebsiella pneumoniae, is on...
A total of 23 clinical isolates (15 Escherichia coli and 8 Klebsiella pneumoniae ), resistant to ...
Purpose: Plasmid-encoded CTX-M-group of extended-spectrum β-lactamases (ESBLs) represent a significa...
The CTX-M-15 extended-spectrum β-lactamase (ESBL) was recently identified in Enterobac-teriaceae iso...
Objective: Extended spectrum beta-lactamase-producing Klebsiella pneumoniae infections cause difficu...
Background & Objectives: CTX-M-type β-lactamases are increasingly becoming the predominant ESBLs glo...
Background: Extended-spectrum β-lactamases (ESBLs) is one of the most important mechanisms of resis...
Introduction: The wideuse of beta-lactam antibacterial agents in the treatment of bacterial infectio...
Background: The aim of this study was to determine a nation-wide prevalence of Ambler class A and D ...
Objective: The aim of this study was to characterize the CTX-M genes in clinical isolates of Klebsie...
Escherichia coli and Klebsiella pneumoniae cause a wide range of infections. Multidrug-resistance st...
Extended-spectrum β-lactamases (ESBL) producing bacteria have been increasingly reported in both hos...